跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (clone) - TGA Drug Approval Details
Approvals
/
TGA
/
TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (clone)
Approved
STANDARD
TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (clone)
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
efe4e171746f35b3
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
efe4e171746f35b3
Product Name
TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (clone)
Artg Id
466066
Artg Name
TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (clone)
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2024-10-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
efe4e171746f35b3
Type
Standard
Back to TGA Approvals